000 03579cam a22004934a 4500
001 14192388
003 OSt
005 20250707085038.0
008 051207s2006 nyua b 001 0 eng
010 _a 2005046669
016 7 _a101263606
_2DNLM
020 _a0824728602
_qalk. paper
020 _a9780824728601
035 _a14192388
035 _a(OCoLC)62736853
040 _aDNLM/DLC
_cDLC
_dYDX
_dNLM
_dBAKER
_dJDR
_dIXA
_dDLC
042 _apcc
050 0 0 _aRE994.I62 2006
060 0 0 _a2006 F-350
060 1 0 _aWB 340
_bI61 2006
082 0 0 _a617.7/061
_222
245 0 0 _aIntraocular Drug Delivery /
_cedited by Glenn J. Jaffe, Paul Ashton, P. Andrew Pearson.
260 _aNew York :
_bTaylor & Francis,
_c2006.
300 _axv, 362 p. :
_bill. (some col.) ;
_c26 cm.
336 _atext
_btxt
_2rdacontent
337 _aunmediated
_bn
_2rdamedia
338 _avolume
_bnc
_2rdacarrier
504 _aIncludes bibliographical references and index.
505 0 0 _g1.
_tRetinal drug delivery /
_rPaul Ashton --
_g2.
_tBlood brain-barrier /
_rDavid A. Antonetti, Thomas W. Gardner, and Alistair J. Barber --
_g3.
_tNeuroprotection /
_rDennis W. Rickman and Melissa J. Mahoney --
_g4.
_tRegulatory issues in drug delivery to the eye /
_rLewis J. Gryziewicz and Scott W. Whitcup --
_g5.
_tAntiangiogenic agents: intravitreal injection /
_rSophie J. Bakri and Peter K. Kaiser --
_g6.
_tIntravitreal antimicrobials /
_rTravis A. Meredith --
_g7.
_tPharmacologic retinal reattachment with INS37217 (denufosol tetrasodium), a nucleotide P2Y₂ receptor agonist /
_rWard M. Peterson --
_g8.
_tCell-based delivery systems: development of encapsulated cell technology for ophthalmic applications /
_rWeng Tao, Rong Wen, Alan Laties, and Gustavo D. Aguirre --
_g9.
_tPhotodynamic therapy /
_rIvana K. Kim and Joan W. Miller --
_g10.
_tThermal-sensitive liposomes /
_rSanjay Asrani, Morton F. Goldberg, and Ran Zeimer --
_g11.
_tGene therapy for retinal disease /
_rAlbert M. Maguire and Jean Bennett --
_g12.
_tBiodegradable systems /
_rHideya Kimura and Yuichiro Ogura --
_g13.
_tTransscleral drug delivery to the retina and choroid /
_rJayakrishna Ambati --
_g14.
_tNondegradable intraocular sustained-release drug delivery devices /
_rMark T. Cahill and Glenn J. Jaffe --
_g15.
_tPhotodynamic therapy in human clinical studies: age-related macular degeneration /
_rIvana K. Kim and Joan W. Miller --
_g16.
_tAge-related macular degeneration drug delivery /
_rKourous A. Rezaei, Sophie J. Bakri, and Peter K. Kaiser --
_g18.
_tDrug delivery for proliferative vitreoretinopathy: prevention and treatment /
_rStephen J. Phillips and Glenn J. Jaffe --
_g19.
_tPharmacologic treatment in diabetic macular edema /
_rZeshan A. Rana and P. Andrew Pearson --
_g20.
_tRetinal vein occlusion /
_rMichael M. Altaweel and Michael S. Ip --
_g21.
_tCytomegalovirus retinitis /
_rCaroline R. Baumal --
_g22.
_tEndophthalmitis /
_rTravis A. Meredith.
650 0 _aOcular pharmacology.
650 0 _aDrug delivery systems.
650 0 _aTherapeutics, Ophthalmological.
650 1 2 _aDrug Delivery Systems.
650 2 2 _aDrug Administration Routes.
650 2 2 _aEye Diseases
_xdrug therapy.
700 1 _aJaffe, Glenn J.
700 1 _aAshton, Paul,
_d1960-
700 1 _aPearson, Andrew,
_d1961-
856 4 2 _3Publisher description
_uhttp://www.loc.gov/catdir/enhancements/fy0648/2005046669-d.html
906 _a7
_bcbc
_corignew
_d1
_eocip
_f20
_gy-gencatlg
942 _2lcc
_cBK
_n0
999 _c3054
_d3054